Document Page: First | Prev | Next | All | Image | This Release | Search

File: aaaau_01.txt
Page: 01
Total Pages: 2

SUBJECT: MALARIA CHEMOPROPHYLAXIS  AND MENINGCLCOCCAL VACINATION)

UNCLASSIFIED


ROUTINE





RATUZYUW RHDJGAAIOO9  2890034-UUUU--RHDIXMP.
ZNR UUUUU
R 101528Z OCT 90
FM NGB ANDREWS AFB MD//SGPi/
TO AIG 7301//CC//SG//
AIG  7311//CC//SG//
RUCIRMA/109AEF MINNEAPOLIS ST PAUL IAP MN//CC//
RUVRBMA/118AES  NASHVILLE  IAP  TN//SG//
RUVOBJA/137AEF WILL ROGERS WORLD APRT OKLAHOMA CITY
       OK//SG/SGNI//
RUVABIA/139AEF  STRATTON ANGA NY//DOCM//
RUVABOA/142AEF  MCCA NEW CASTLE DE//DOCM//
RUWFPAA/146AES  CHANNEL ISLANDS ANGB CA//SGA//
RUVRBIA/156AEF  CHARLOTTE DOUGLAS IAP NC//CC//
RUVRBPA/167AEF  EWVRA SHEPPAAD FLD MARTINSBURG  WV//SGO//
RUVRBGA/183AEF  ALLEN C THOMPSON FLD MS//SG//
RUVHBKA/ 187AEF CHEYENNE MUNI APRT WY//SGO//
ZEN 113TFW ANDREWS AFB MD//SG//
ZEN NGB  ANDREWS  AFB MD//SGAX//SGAT//
BT
UNCLAS
QQQQ

SUBJECT: MALARIA CHEMOPROPHYLAXIS  AND MENINGCLCOCCAL VACINATION)
GUIDELINES FOR OPERATION DESERT SHIELD REFERENCES:  DA WASHINGTON
DC//SGPS-PSP-D MSG, 3117OOZ AUG 90.  SAME SUBJECT.
B.  HQ USAF/SGP LTR, 6 NOV 89.  AIR FORCE GUIDELINES FOR MALARIA
PROPHYLAXIS.
C.  HO USAF BOLLING AFB DC//SGPA MSG 072000Z SEP 90, SAME SUBJECT.
1.  MALARIA CHEMOPROPHYLAXIS INFORMATION PROVIDED BY THE ARMED FORCES
MEDICAL INTELLIGENCE CENTER  (AFMIC) AND OTHER SOURCES INDICATE THE
FOLLOWING NOTE THAT THIS IS A CHANGE  IN  ANG  POLICY:
A. NOT ALL INDIVIDUALS OR UNITS DEPLOYED FOR OPERATION DESERT SHIELD
NEED TO BE STARTED ON MALARIA PROPHYLAXIS.
B. NO CURRENT MALARIA TRANSMISSION HAS  BEEN  IDENTIFIED  IN  EASTERN
SAUDI ARABIA, BAHRAIN, JORDAN, KUWAIT, QATAR, OR THE UNITED ARAB
EMIRATES.  RIYADH, JEODAH, AND DHAHRAN ARE CONSIDERED RISK FREE.
--- INDIVIDUALS DEPLOYING TO THESE AREAS ARE NOT REQUIRED TO CONSUME
MALARIA PROPHYLAXIS--- HOWEVER, A MINIMUM OF A SIX-WEEK SUPPLY  (6
TABLETS) OF CHLOROQUINE PHOSPHATE TABLETS  QNSN: 6505-00-117-6450), OR
DOXYCYCLINE SHOULD BE ISSUED TO ALL INDIVIDUALS SINCE FUTURE
OPERATIONS MAY INCLUDE TRAVEL TO  MALARIA  AREAS.
C. INDIVIDUALS DEPLOYING TO UNKNOWN SITES, OR WITH  A  HIGH  RISK  OF
DIVERTING, OR DEPLOYING THROUGH, AREAS OF KNOWN MALARIA RISK SHOULD
BE STARTED ON  CHLOROQUINE  PROPHYLAXIS.
D. IN SAUDI ARABIA, MALARIA TRANSMISSION OCCURS YEAR ROUND BUT IS
LIMITED-TO THE WESTERN PROVINCES, WITH THE MAIN THREAT IN THE
SOUTHWEST.  LIMITED MALARIA TRANSMISSION OCCURS IN EGYPT,  IRAQ,
TURKEY, AND OMAN.  TRANSMISSION IS WIDESPREAD IN NORTH YEMEN, SOUTH
YEMEN, AND  IRAN.
E. SUMMARY GUIDELINES FOR MALARIA PROPHYLAXIS:
;I) ALL SHOULD BE ISSUED DOXYCYCLINE OR CHLOROQUINE.
;2) INDIVIDUALS GOING TO HAZARDOUS OR UNKNOWN AREAS SHOULD TAKE THEIR
MALARIA PROPHYLAXIS  (A OR B BELOW): -
A) DOXYCYCLINE (DOXYCYCLINE 100 MG  PO  QD  BEGINING  3
DAYS PRIOR, DURING, AND FOR 28 DAYS AFTER  TRAVEL  TO  A MALARIA HAZARD
AREA).  DOXYCYCLINE IS PREFERRED DUE  TO  ADDED  COVERAGE OF MANY OTHER
PATHOGENS CAUSING DIARREHA.  THIS IS THE RECOMMENDED MALARIA
POPHYLAXIS FOR FLYING PERSONELL, AND MAY BE CONSIDERED FOR USE EVEN


                                         UNCLASSIFIED                                     


Document Page: First | Prev | Next | All | Image | This Release | Search